Activities

Exploring
1) Exploring the role and potential therapeutic use of pHe and pO2 in cancer proliferation, progression, metastasis and neurodegenerative disorders.
Implementing
2) Implementing quantitative criteria in for the non-invasive evaluations of animal models in oncology/neurodegenerative disorders and their response to therapies.
Developing
3) Developing liposomal nanoformulations “a la carte” to improve pharmaceutical performance.
Producing
4) Producing hybrid MRI/PET probes to assess vascular performance in cancer and neurodegerative disorders.
Teaching
5) Teaching and dissemination.